MAPT and Alzheimer disease: An intracerebroventricular dose of AdipoQ recovered cognitive decline and reduced glycogen synthase kinase 3β (GSK3β)-induced tau hyperphosphorylation in AD-related areas in a rat paradigm of streptozotocin-mediated brain pathology (Xu et al., 2018).